Overview
- More than 62,000 people in England could benefit from the new NHS-backed option for debilitating hand eczema.
- The treatment, marketed as Anzupgo by Leo Pharma, is expected to be available on the NHS within 90 days.
- Adults apply the cream twice daily to affected areas on the hands and wrists at home.
- NICE recommends the therapy for patients for whom steroid creams have failed or are unsuitable.
- The option may reduce reliance on phototherapy and on oral retinoids that carry systemic side effects.